Current primary outcome measure as of 18/01/2021: The main objective of the trial is to assess the effectiveness of the interventions in reducing time to recovery and in reducing the incidence of hospitalisation and/or death.The trial has co-primary endpoints: 1. Time taken to self-reported recovery; defined as the first instance that a participant reports feeling recovered from possible COVID-19 2. Hospitalisation and/or death Both collected within 28 days of randomisation from patient report; study partner report; medical records; daily online symptom scores . _____ Previous primary outcome measure as of 10/06/2020: Hospital admission or mortality related to suspected COVID-19 infection assessed using reports of patients’ medical records; from enrolment up to 28 days after completing treatment _____ Previous primary outcome measure as of 08/06/2020: Hospital admission or mortality related to suspected COVID-19 infection. _____ Previous primary outcome measure: Hospital admission or death; for patients aged =50 years with comorbidity; and aged =65 years with or without comorbidity and suspected COVID-19 infection during time of prevalent COVID-19 infections; measured by hospital admission or mortality related to suspected COVID-19 within 28 days

Current primary outcome measure as of 18/01/2021: The main objective of the trial is to assess the effectiveness of the interventions in reducing time to recovery and in reducing the incidence of hospitalisation and/or death.The trial has co-primary endpoints: 1. Time taken to self-reported recovery; defined as the first instance that a participant reports feeling recovered from possible COVID-19 2. Hospitalisation and/or death Both collected within 28 days of randomisation from patient report; study partner report; medical records; daily online symptom scores . _____ Previous primary outcome measure as of 10/06/2020: Hospital admission or mortality related to suspected COVID-19 infection assessed using reports of patients’ medical records; from enrolment up to 28 days after completing treatment _____ Previous primary outcome measure as of 08/06/2020: Hospital admission or mortality related to suspected COVID-19 infection. _____ Previous primary outcome measure: Hospital admission or death; for patients aged =50 years with comorbidity; and aged =65 years with or without comorbidity and suspected COVID-19 infection during time of prevalent COVID-19 infections; measured by hospital admission or mortality related to suspected COVID-19 within 28 days

Current primary outcome measure as of 10/06/2020: Hospital admission or mortality related to suspected COVID-19 infection assessed using reports of patients’ medical records; from enrolment up to 28 days after completing treatment _____ Previous primary outcome measure as of 08/06/2020: Hospital admission or mortality related to suspected COVID-19 infection. _____ Previous primary outcome measure: Hospital admission or death; for patients aged =50 years with comorbidity; and aged =65 years with or without comorbidity and suspected COVID-19 infection during time of prevalent COVID-19 infections; measured by hospital admission or mortality related to suspected COVID-19 within 28 days

Current primary outcome measure as of 10/06/2020: Hospital admission or mortality related to suspected COVID-19 infection assessed using reports of patients’ medical records; from enrolment up to 28 days after completing treatment _____ Previous primary outcome measure as of 08/06/2020: Hospital admission or mortality related to suspected COVID-19 infection. _____ Previous primary outcome measure: Hospital admission or death; for patients aged =50 years with comorbidity; and aged =65 years with or without comorbidity and suspected COVID-19 infection during time of prevalent COVID-19 infections; measured by hospital admission or mortality related to suspected COVID-19 within 28 days